Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« Outcomes in patients on alemtuzumab with thyroid adverse events Next Article
Lesion-specific perfusion levels affect myelin loss and repair »
« Outcomes in patients on alemtuzumab with thyroid adverse events Next Article
Lesion-specific perfusion levels affect myelin loss and repair »
Table of Contents: MS Virtual 2020
Featured articles
COVID-19 and MS
Biomarkers
Treatment Strategies and Results
Management of progressive MS with approved DMT
Novel Treatment Directions
Neuromyelitis Optica Spectrum Disorders
Miscellaneous Topics
Related Articles
November 25, 2020
Predictive value of CSF Aβ and tau proteins in MS

December 20, 2022
Stem cell transplantation not superior to natalizumab in progressive MS
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy